Elite Pharmaceuticals, Inc. Other Asset Impairment Charges
Elite Pharmaceuticals, Inc. (ELTP) reported Other Asset Impairment Charges of $847.01 thousand for the 12-month period ending 2026-03-31, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2026-08-13
- Elite Pharmaceuticals, Inc. other asset impairment charges for fiscal 2025 was $1.60M.
| Period end | Other Asset Impairment Charges 12 month |
|---|---|
| 2026-03-31 | $847.01K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.60M 10-K · filed 2026-06-29 |